Back
10x Genomics Vs. P3 Health Partners Industry Stock Comparison
Sell
34
TXG
10x Genomics
Last Price:
14.14
Seasonality Move:
17.75%
Sell
37
PIII
P3 Health Partners
Last Price:
0.22
Seasonality Move:
-51.13%
Sell
34
10x Genomics (TXG)
is a Sell
Is 10x Genomics a Buy, Sell or Hold?
- The current 10x Genomics [TXG] share price is $14.12. The Score for TXG is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- TXG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
P3 Health Partners (PIII)
is a Sell
Is P3 Health Partners a Buy, Sell or Hold?
- The current P3 Health Partners [PIII] share price is $0.21. The Score for PIII is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- PIII is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TXG Stock Price Chart
What is 10x Genomics's stock price today?
-
The 10x Genomics share price today is $14.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TXG is experiencing selling pressure, which indicates risk of future bearish movement.
PIII Stock Price Chart
What is P3 Health Partners's stock price today?
-
The P3 Health Partners share price today is $0.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PIII is experiencing selling pressure, which indicates risk of future bearish movement.
TXG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.89 | Sell |
| Relative Strength Index (14 RSI): | 32.22 | Sell |
| Chaikin Money Flow: | -2154696 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.17 - 16.47) | Sell |
| Bollinger Bands (100): | (16.73 - 22.05) | Sell |
PIII Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 26.35 | Sell |
| Chaikin Money Flow: | -1010409 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.31 - 0.43) | Sell |
| Bollinger Bands (100): | (0.37 - 0.57) | Sell |
TXG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.8 | Sell |
| 20-day SMA: | 15.79 | Sell |
| 50-day SMA: | 18.76 | Sell |
| 200-day SMA: | 26.31 | Sell |
| 8-day EMA: | 15.44 | Sell |
| 20-day EMA: | 16.19 | Sell |
| 50-day EMA: | 17.91 | Sell |
| 200-day EMA: | 25.66 | Sell |
PIII Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.34 | Sell |
| 20-day SMA: | 0.38 | Sell |
| 50-day SMA: | 0.4 | Sell |
| 200-day SMA: | 0.63 | Sell |
| 8-day EMA: | 0.32 | Sell |
| 20-day EMA: | 0.36 | Sell |
| 50-day EMA: | 0.4 | Sell |
| 200-day EMA: | 0.71 | Sell |
10x Genomics Earnings Growth & TXG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.05 per share.
P3 Health Partners Earnings Growth & PIII Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $0.42 per share.
10x Genomics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
P3 Health Partners Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||